Concepedia

Martin Treder

MT

17

Publications

890

Citations

15

H-Index

2000

Active since

Affiliations

Affimed Therapeutics (Germany)(Current)

Amgen (United States)

Max Planck Institute of Biochemistry

Universidade de Santiago de Compostela

Martin Treder is an author at Affimed Therapeutics (Germany) specializing in medicine, immunology, and cell biology.

Top concepts

Publications per year

2000–2022

17

Publications

17

Cloning and Characterization of Secretory Tyrosine Phosphatases of <i>Mycobacterium tuberculosis</i>

Anil Koul, Axel Choidas, Martin Treder et al. · Journal of Bacteriology · 2000 · 178 citations · Full text

Combining AFM13, a Bispecific CD30/CD16 Antibody, with Cytokine-Activated Blood and Cord Blood–Derived NK Cells Facilitates CAR-like Responses Against CD30+ Malignancies

Lucila Nassif Kerbauy, Nancy D. Marín, Mecit Kaplan et al. · Clinical Cancer Research · 2021 · 147 citations · Full text

CD16A Activation of NK Cells Promotes NK Cell Proliferation and Memory-Like Cytotoxicity against Cancer Cells

Jens Pahl, Joachim Koch, Jana-Julia Götz et al. · Cancer Immunology Research · 2018 · 127 citations

Preclinical evaluation of AFM24, a novel CD16A-specific innate immune cell engager targeting EGFR-positive tumors

Susanne Wingert, Uwe Reusch, Stefan Knackmuss et al. · mAbs · 2021 · 62 citations · Full text

Redirected optimized cell killing (ROCK®): A highly versatile multispecific fit-for-purpose antibody platform for engaging innate immunity

Kristina Ellwanger, Uwe Reusch, Ivica Fucek et al. · mAbs · 2019 · 60 citations · Full text

, , +19

Rows per page

1–5 of 17